Pharmaceutical manufacturers of Phentermine

Sun Pharma is a global, comprehensive, specialized pharmaceutical company with production facilities for API and FDF in India, the United States, Latin America, and Europe. It produces and sells a wide range of pharmaceutical formulations as branded generics and generic drugs in India, the US, and various other global markets. It is supported by 2 advanced R&D Centers with a team of over 600 scientists for projects in Chemical Synthesis, Clinical Research, and formulation development. Sun is a frontrunner in specific therapy areas and possesses robust expertise in product development, process chemistry, and manufacturing.

OLON Group is a prominent worldwide firm specializing in the creation and manufacture of active pharmaceutical ingredients for CDMO and Generics. It serves as a dependable and preferred partner for the pharmaceutical, biotech, and specialty ingredients sectors. With a 2021 turnover of 580 million dollars, OLON provides 300 APIs for the Generic market. The company benefits from a workforce of 2,300 employees, including a highly skilled R&D team of over 300 individuals. This enables OLON to offer comprehensive integrated packages and services to facilitate the full development of APIs, leveraging extensive expertise in both Chemical and Biological processes, all within a full cGMP and regulatory framework. OLON holds approximately 160 active US DMFs and 79 granted CoS. OLON's headquarters is located in Rodano, near Milan, Italy, and it operates 11 manufacturing facilities - 8 in Italy, 1 in Spain, 1 in the USA, and 1 in India. These facilities are designed in accordance with the most stringent international standards. Additionally, OLON has 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China).

Situated in Hyderabad, India, Symed Labs Ltd is a prominent and innovative producer of Active Pharmaceutical Ingredients (APIs) & a comprehensive solution provider for the pharmaceutical sector for chemistry related services. Symed labs has autonomously created processes for more than fifty APIs across various therapeutic categories in the laboratory and upscaled them to plant, as well as vending them to over 600 clients in 30 nations in the regulated and less regulated markets

Moehs Ibérica is the headquarters of the MOEHS Group. Moehs Ibérica currently has 138 employees in the following departments: Accounting/Treasury, Purchasing/Logistics, Sales/Marketing, Human Resources, IT, Quality Assurance/Regulatory Affairs, Research and Intellectual Property. It provides services to the entire group and each of its subsidiaries. In addition, it has its own R&D building with all its services and a plant dedicated to the production of small quantities of ingredients for the pharmaceutical industry, as well as a plant for the manufacture of High Potency Active Ingredients.

Viyash embodies integrity and guidance in all aspects. As a fully-integrated pharmaceutical firm, we possess a robust collection of unique formulations, APIs, and advanced intermediates. Viyash and its affiliated companies manage 10 API/Intermediate facilities, boasting a combined capacity of approximately 2000 KL and diverse capabilities across various categories - small/large volume, potent/non-potent, regulated/semi-regulated markets. Additionally, we oversee a formulation manufacturing facility in New Jersey, USA, with a capacity of around 1.2 billion units.

Established in 1980 by microbiologist Mr. M L N Sastry, Malladi Drugs & Pharmaceuticals Ltd quickly emerged as a pioneer in the production of ephedrine and pseudoephedrine salts. Today, it holds a prominent position as a manufacturer of APIs in the cough and cold segment, as well as in therapeutic segments such as antihistamines, anti-convulsants, anti-depressants, and anxiolytics (CNS). With a vast export network spanning approximately 60 countries, the company derives over 85% of its revenue from international markets. Malladi's manufacturing units have received approval from prominent regulatory bodies including the FDA, EDQM, KFDA, and TGA.

Since the establishment of our company SAMHWA in 1991, we have been committed to the principles of faithfulness, harmony, and trust, driving continuous improvement in technical development and human resources. With extensive experience and expertise, we specialize in fabricating major items such as piping, coils, headers, and pressure parts for boilers. Our top priorities are environmental sustainability and safety, as reflected in our impeccable safety record at the workshop. We are dedicated to constantly evolving and enhancing our business management to foster innovation and meet new challenges. SAMHWA isn't just a manufacturer and seller of products.

Founded in 1953, Chemische Fabrik Berg GmbH transitioned from manufacturing basic barbiturates to positioning itself as a recognized supplier of intricate molecules requiring multi-stage synthesis on the global stage. Renowned in the supplier markets for human and veterinary pharmaceuticals, we specialize in the production of APIs, controlled substances, and advanced intermediates.